Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification

BACKGROUND: Adalimumab blocks the action of tumor necrosis factor-α and reduces disease progression in rheumatoid arthritis and psoriatic arthritis. The effects of adalimumab in controlling progression of structural damage in erosive hand osteoarthritis (HOA) were assessed. METHODS: Sixty patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbruggen, Gust, Wittoek, Ruth, Cruyssen, Bert Vander, Elewaut, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371224/
https://www.ncbi.nlm.nih.gov/pubmed/22128078
http://dx.doi.org/10.1136/ard.2011.149849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371224/
https://www.ncbi.nlm.nih.gov/pubmed/22128078
http://dx.doi.org/10.1136/ard.2011.149849

Ejemplares similares